Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs) (EOLE)

This study has been completed.
Sponsor:
Collaborators:
Readitwell
Lincoln Medical and Mental Health Center
Information provided by (Responsible Party):
Abbott
ClinicalTrials.gov Identifier:
NCT01103596
First received: February 24, 2010
Last updated: December 13, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)